-
1
-
-
0032862564
-
Somatic mutations at the SRD5A2 locus encoding prostatic steroid 5alpha- Reductase during prostate cancer progression
-
DOI 10.1016/S0022-5347(01)61683-5
-
Akalu A, Dlmajian DA, Highshaw RA, Nichols PW, Reichardt JK. Somatic mutations at the SRD5A2 locus encoding prostatic steroid 5α-reductase during prostate cancer progression. J Urol. 1999;161:1355-1358. (Pubitemid 29426156)
-
(1999)
Journal of Urology
, vol.161
, Issue.4
, pp. 1355-1358
-
-
Akalu, A.1
Elmajian, D.A.2
Highshaw, R.A.3
Nichols, P.W.4
Reichardt, J.K.V.5
-
2
-
-
0003089903
-
-
Lepor H, Lawson RK eds. Philadelphia, PA: Saunders
-
Coffey DS. In: Lepor H, Lawson RK eds. The Molecular Biology of the Prostate. Philadelphia, PA: Saunders; 1993;28-56.
-
(1993)
The Molecular Biology of the Prostate
, pp. 28-56
-
-
Coffey, D.S.1
-
3
-
-
34548217770
-
Low-Activity V89L Variant in SRD5A2 Is Associated with Aggressive Prostate Cancer Risk: An Explanation for the Adverse Effects Observed in Chemoprevention Trials Using 5-Alpha-Reductase Inhibitors
-
DOI 10.1016/j.eururo.2007.04.008, PII S030228380700471X
-
Cussenot O, Azzouzi AR, Nicolaiew N, Mangin P, Cormier L, Fournier G, Valeri A, Cancel-Tassin G. Low-activity V89L variant in SRD5A2 is associated with aggressive prostate cancer risk: an explanation for the adverse effects observed in chemoprevention trials using 5-alpha-reductase inhibitors. Eur Urol. 2007;52:1082-1087. (Pubitemid 47337033)
-
(2007)
European Urology
, vol.52
, Issue.4
, pp. 1082-1089
-
-
Cussenot, O.1
Azzouzi, A.-R.2
Nicolaiew, N.3
Mangin, P.4
Cormier, L.5
Fournier, G.6
Valeri, A.7
Cancel-Tassin, G.8
-
4
-
-
0033233173
-
The V89L polymorphism in the 5alpha-reductase type 2 gene and risk of prostate cancer
-
Febbo PG, Kantoff PW, Platz EA, Casey D, Batter S, Giovannucci E, Hennekens CH, Stampfer MJ. The V89L polymorphism in the 5-reductase type 2 gene and risk of prostate cancer. Cancer Res. 1999;59:5878-5881. (Pubitemid 30004943)
-
(1999)
Cancer Research
, vol.59
, Issue.23
, pp. 5878-5881
-
-
Febbo, P.G.1
Kantoff, P.W.2
Platz, E.A.3
Casey, D.4
Batter, S.5
Giovannucci, E.6
Hennekens, C.H.7
Stampfer, M.J.8
-
5
-
-
0021334278
-
Tissue dihydrotestosterone levels and clinical response to hormonal therapy in patients with advanced prostate cancer
-
Geller J, de la Vega DJ, Albert JD, Nachtsheim DA. Tissue dihydrotestosterone levels and clinical response to hormonal therapy in patients with advanced prostate cancer. J Clin Endocrinol Metab. 1984;58:36-40. (Pubitemid 14220514)
-
(1984)
Journal of Clinical Endocrinology and Metabolism
, vol.58
, Issue.1
, pp. 36-40
-
-
Geller, J.1
De La Vega, D.J.2
Albert, J.D.3
Nachtsheim, D.A.4
-
6
-
-
24644440563
-
The 5alpha-reductase type II A49T and V89L high-activity allelic variants are more common in men with prostate cancer compared with the general population
-
DOI 10.1016/j.eururo.2005.06.011, PII S0302283805003775
-
Giwercman YL, Abrahamsson PA, Giwercman A, Gadaleanu V, Ahlgren G. The 5alpha-reductase type II A49T and V89L high-activity allelic variants are more common in men with prostate cancer compared with the general population. Eur Urol. 2005;48:679-685. (Pubitemid 41278596)
-
(2005)
European Urology
, vol.48
, Issue.4
, pp. 679-685
-
-
Giwercman, Y.L.1
Abrahamsson, P.-A.2
Giwercman, A.3
Gadaleanu, V.4
Ahlgren, G.5
-
7
-
-
33846647414
-
5alpha-reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia
-
DOI 10.1002/ijc.22408
-
Hayes VM, Severi G, Padilla EJ, Morris HA, Tilley WD, Southey MC, English DR, Sutherland RL, Hopper JL, Boyle P, Giles GG. 5Alpha-reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia. Int J Cancer. 2007;120:776-780. (Pubitemid 46175396)
-
(2007)
International Journal of Cancer
, vol.120
, Issue.4
, pp. 776-780
-
-
Hayes, V.M.1
Severi, G.2
Padilla, E.J.D.3
Morris, H.A.4
Tilley, W.D.5
Southey, M.C.6
English, D.R.7
Sutherland, R.L.8
Hopper, J.L.9
Boyle, P.10
Giles, G.G.11
-
8
-
-
2342558431
-
Androgen receptor in prostate cancer
-
Heinlein CA, Chang C. Androgen receptor in prostate cancer. Endocr Rev. 2004;25:276-308.
-
(2004)
Endocr Rev
, vol.25
, pp. 276-308
-
-
Heinlein, C.A.1
Chang, C.2
-
9
-
-
0034788128
-
Polymorphic markers in the SRD5A2 gene and prostate cancer risk: A population-based case-control study
-
Hsing AW, Chen C, Chokkalingam AP, Gao YT, Dightman DA, Nguyen HT, Deng J, Cheng J, Sesterhenn IA, Mostofi K, Stanczyk FZ, Reichardt JKV. Polymorphic markers in the SRD5A2 gene and prostate cancer risk: a population-based case-control study. Cancer Epidemiol Biomark Prev. 2001;10:1077-1082. (Pubitemid 32959155)
-
(2001)
Cancer Epidemiology Biomarkers and Prevention
, vol.10
, Issue.10
, pp. 1077-1082
-
-
Hsing, A.W.1
Chen, C.2
Chokkalingam, A.P.3
Gao, Y.-T.4
Dightman, D.A.5
Nguyen, H.T.6
Deng, J.7
Cheng, J.8
Sesterhenn, I.A.9
Mostofi, F.K.10
Stanczyk, F.Z.11
Reichardt, J.K.V.12
-
10
-
-
0034654218
-
Association of SRD5A2 genotype and pathological characteristics of prostate tumors
-
Jaffe JM, Malkowicz SB, Walker AH, MacBride S, Peschel R, Tomaszewski J, Van Arsdalen K, Wein AJ, Rebbeck TR. Association of SRD5A2 genotype and pathological characteristics of prostate tumors. Cancer Res. 2000;60:1626-1630. (Pubitemid 30183434)
-
(2000)
Cancer Research
, vol.60
, Issue.6
, pp. 1626-1630
-
-
Jaffe, J.M.1
Malkowicz, S.B.2
Walker, A.H.3
MacBride, S.4
Peschel, R.5
Tomaszewski, J.6
Van Arsdalen, K.7
Wein, A.J.8
Rebbeck, T.R.9
-
11
-
-
57349182464
-
Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control
-
Jemal A, Thun MJ, Ries LA, Howe HL, Weir HK, Center MM, Ward E, Wu XC, Eheman C, Anderson R, Ajani UA, Kohler B, Edwards BK. Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst. 2008;100:1672-1694.
-
(2008)
J Natl Cancer Inst
, vol.100
, pp. 1672-1694
-
-
Jemal, A.1
Thun, M.J.2
Ries, L.A.3
Howe, H.L.4
Weir, H.K.5
Center, M.M.6
Ward, E.7
Wu, X.C.8
Eheman, C.9
Anderson, R.10
Ajani, U.A.11
Kohler, B.12
Edwards, B.K.13
-
12
-
-
0030974511
-
A polymorphism of the 5alpha-reductase gene and its association with prostate cancer: A case-control analysis
-
Kantoff PW, Febbo PG, Giovannucci E, Krithivas K, Dahl DM, Chang G, Hennekens CH, Brown M, Stampfer MJ. A polymorphism of the 5-reductase gene and its association with prostate cancer: a case-control analysis. Cancer Epidemiol Biomark Prev. 1997;6:189-192. (Pubitemid 27118466)
-
(1997)
Cancer Epidemiology Biomarkers and Prevention
, vol.6
, Issue.3
, pp. 189-192
-
-
Kantoff, P.W.1
Febbo, P.G.2
Giovannucci, E.3
Krithivas, K.4
Dahl, D.M.5
Chang, G.6
Hennekens, C.H.7
Brown, M.8
Stampfer, M.J.9
-
13
-
-
0035446824
-
Prostate carcinoma risk and allelic variants of genes involved in androgen biosynthesis and metabolism pathways
-
DOI 10.1002/1097-0142(20010901)92:5<1130::AID-CNCR1430>3.0.CO;2-B
-
Latil AG, Azzouzi R, Cancel GS, Guillaume EC, Cochan-Priollet B, Berthon PL, Cussenot O. Prostate carcinoma risk and allelic variants of genes involved in androgen biosynthesis and metabolism pathways. Cancer. 2001;92:1130-1137. (Pubitemid 32861661)
-
(2001)
Cancer
, vol.92
, Issue.5
, pp. 1130-1137
-
-
Latil, A.G.1
Azzouzi, R.2
Cancel, G.S.3
Guillaume, E.C.4
Cochan-Priollet, B.5
Berthon, P.L.6
Cussenot, O.7
-
14
-
-
0032846313
-
Prostate cancer risk and polymorphism in 17 hydroxylase (CYP17) and steroid reductase (SRD5A2)
-
Lunn RM, Bell DA, Mohler JL, Taylor JA. Prostate cancer risk and polymorphism in 17 hydroxylase (CYP17) and steroid reductase (SRD5A2). Carcinogenesis. 1999;20:1727-1731.
-
(1999)
Carcinogenesis
, vol.20
, pp. 1727-1731
-
-
Lunn, R.M.1
Bell, D.A.2
Mohler, J.L.3
Taylor, J.A.4
-
15
-
-
0033936410
-
Biochemical and pharmacogenetic dissection of human steroid 5alpha-reductase type II
-
Makridakis NM, di Salle E, Reichardt JK. Biochemical and pharmacogenetic dissection of human steroid 5alpha-reductase type II. Pharmacogenetics. 2000;10:407-413.
-
(2000)
Pharmacogenetics
, vol.10
, pp. 407-413
-
-
Makridakis, N.M.1
Di Salle, E.2
Reichardt, J.K.3
-
16
-
-
0033581453
-
Association of mis-sense substitution in SRD5A2 gene with prostate cancer in African-American and Hispanic men in Los Angeles, USA
-
Makridakis NM, Ross RK, Pike MC, Crocitto LE, Kolonel LN, Pearce CL, Henderson BE, Reichardt JK. Association of mis-sense substitution in SRD5A2 gene with prostate cancer in African-American and Hispanic men in Los Angeles, USA. Lancet. 1999;354:975-978.
-
(1999)
Lancet
, vol.354
, pp. 975-978
-
-
Makridakis, N.M.1
Ross, R.K.2
Pike, M.C.3
Crocitto, L.E.4
Kolonel, L.N.5
Pearce, C.L.6
Henderson, B.E.7
Reichardt, J.K.8
-
17
-
-
0035906834
-
A missense substitution A49T in the steroid 5-alpha-reductase gene (SRD5A2) is not associated with prostate cancer in Finland
-
DOI 10.1054/bjoc.2001.1789
-
Mononen N, Ikonen T, Syrjakoski K, Matikainen M, Schleutker J, Tammela TLJ, Koivisto PA, Kallioniemi OP. A missense substitution A49T in the steroid 5-reductase gene (SRD5A2) is not associated with prostate cancer in Finland. Br J Cancer. 2001;84:1344-1347. (Pubitemid 32522102)
-
(2001)
British Journal of Cancer
, vol.84
, Issue.10
, pp. 1344-1347
-
-
Mononen, N.1
Ikonen, T.2
Syrjakoski, K.3
Matikainen, M.4
Schleutker, J.5
Tammela, T.L.J.6
Koivisto, P.A.7
Kallioniemi, O.P.8
-
18
-
-
0035156454
-
V89L polymorphism of type-2, 5-alpha reductase enzyme gene predicts prostate cancer presence and progression
-
DOI 10.1016/S0090-4295(00)00928-6, PII S0090429500009286
-
Nam RK, Toi A, Vesprini D, Ho M, Chu W, Harvie S, Sweet J, Trachtenberg J, Jewett MA, Narod SA. V89L polymorphism of type-2, 5-reductase enzyme gene predicts prostate cancer presence and progression. Urology. 2001;57:199-205. (Pubitemid 32065856)
-
(2001)
Urology
, vol.57
, Issue.1
, pp. 199-204
-
-
Nam, R.K.1
Toi, A.2
Vesprini, D.3
Ho, M.4
Chu, W.5
Harvie, S.6
Sweet, J.7
Trachtenberg, J.8
Jewett, M.A.S.9
Narod, S.A.10
-
20
-
-
0035474113
-
Heterogeneity of genetic alterations in prostate cancer: Evidence of the complex nature of the disease
-
Nwosu V, Carpten J, Trent JM, Sheridan R. Heterogeneity of genetic alterations in prostate cancer: evidence of the complex nature of the disease. Hum Mol Genet. 2001;10:2313-2318. (Pubitemid 32998847)
-
(2001)
Human Molecular Genetics
, vol.10
, Issue.20
, pp. 2313-2318
-
-
Nwosu, V.1
Carpten, J.2
Trent, J.M.3
Sheridan, R.4
-
21
-
-
33847690738
-
The association of 5alpha-reductase II (SRD5A2) and 17 hydroxylase (CYP17) gene polymorphisms with prostate cancer patients in the Turkish population
-
DOI 10.1089/dna.2006.0534
-
Onen IH, Ekmekci A, Eroglu M, Polat F, Biri H. The association of 5alpha-reductase II (SRD5A2) and 17 hydroxylase (CYP17) gene polymorphisms with prostate cancer patients in the Turkish population. DNA Cell Biol. 2007;26:100-107. (Pubitemid 46363875)
-
(2007)
DNA and Cell Biology
, vol.26
, Issue.2
, pp. 100-107
-
-
Onen, I.H.1
Ekmekci, A.2
Eroglu, M.3
Polat, F.4
Biri, H.5
-
22
-
-
0000895983
-
-
Lyon, France: IARC
-
Parkin DM, Whelan SL, Ferlaym J, Raymond L, Young J. Cancer Incidence in Five Continents. Vol 2. Lyon, France: IARC; 1997.
-
(1997)
Cancer Incidence in Five Continents
, vol.2
-
-
Parkin, D.M.1
Whelan, S.L.2
Ferlaym, J.3
Raymond, L.4
Young, J.5
-
23
-
-
33947246101
-
Phenotypic heterogeneity of mutations in androgen receptor gene
-
DOI 10.1111/j.1745-7262.2007.00250.x
-
Rajender S, Singh L, Thangaraj K. Phenotypic heterogeneity of mutations in androgen receptor gene. Asian J Androl. 2007;9:147-179. (Pubitemid 46416577)
-
(2007)
Asian Journal of Andrology
, vol.9
, Issue.2
, pp. 147-179
-
-
Rajender, S.1
Singh, L.2
Thangaraj, K.3
Lee, W.M.4
-
24
-
-
0029093031
-
Genetic variability of the human SRD5A2 gene: Implications for prostate cancer risk
-
Reichardt JK, Makridakis N, Henderson BE, Yu MC, Pike MC, Ross RK. Genetic variability of the human SRD5A2 gene: implications for prostate cancer risk. Cancer Res. 1995;55:3973-3975.
-
(1995)
Cancer Res
, vol.55
, pp. 3973-3975
-
-
Reichardt, J.K.1
Makridakis, N.2
Henderson, B.E.3
Yu, M.C.4
Pike, M.C.5
Ross, R.K.6
-
25
-
-
0026553251
-
5-Reductase activity and risk of prostate cancer among Japanese and US white and black males
-
Ross RK, Bernstein L, Lobo RA, Shimizu FZ, Stanczyk FZ, Pike MC, Henderson BE. 5-Reductase activity and risk of prostate cancer among Japanese and US white and black males. Lancet. 1992;339:887-889.
-
(1992)
Lancet
, vol.339
, pp. 887-889
-
-
Ross, R.K.1
Bernstein, L.2
Lobo, R.A.3
Shimizu, F.Z.4
Stanczyk, F.Z.5
Pike, M.C.6
Henderson, B.E.7
-
26
-
-
21844447090
-
Associations between polymorphisms in the steroid 5-alpha reductase type II (SRD5A2) gene and benign prostatic hyperplasia and prostate cancer
-
DOI 10.1016/j.urolonc.2004.12.014, PII S1078143905000037, Contemporary Clinical Trials in Urologic Oncology
-
Salam MT, Ursin G, Skinner EC, Dessissa T, Reichardt JK. Associations between polymorphisms in the steroid 5-alpha reductase type II (SRD5A2) gene and benign prostatic hyperplasia and prostate cancer. Urol Oncol. 2005;23:246-253. (Pubitemid 40961936)
-
(2005)
Urologic Oncology: Seminars and Original Investigations
, vol.23
, Issue.4
, pp. 246-253
-
-
Salam, M.T.1
Ursin, G.2
Skinner, E.C.3
Dessissa, T.4
Reichardt, J.K.V.5
-
27
-
-
33744824667
-
CYP17, SRD5A2, CYP1B1, and CYP2D6 gene polymorphisms with prostate cancer risk in North Indian population
-
DOI 10.1089/dna.2006.25.287
-
Sobti RC, Onsory K, Al-Badran AI, Kaur P, Watanabe M, Krishan A, Mohan H. CYP17, SRD5A2, CYP1B1, and CYP2D6 gene polymorphisms with prostate cancer risk in North Indian population. DNA Cell Biol. 2006;25:287-294. (Pubitemid 43830442)
-
(2006)
DNA and Cell Biology
, vol.25
, Issue.5
, pp. 287-294
-
-
Sobti, R.C.1
Onsory, K.2
Al-Badran, A.I.3
Kaur, P.4
Watanabe, M.5
Krishan, A.6
Mohan, H.7
-
28
-
-
0036016312
-
5Alpha-reductase 2 polymorphisms as risk factors in prostate cancer
-
Soderstrom T, Wadelius M, Andersson SO, Johansson JE, Johansson S, Granath F, Rane A. 5Alpha-reductase 2 polymorphisms as risk factors in prostate cancer. Pharmacogenetics. 2002;12:307-312.
-
(2002)
Pharmacogenetics
, vol.12
, pp. 307-312
-
-
Soderstrom, T.1
Wadelius, M.2
Andersson, S.O.3
Johansson, J.E.4
Johansson, S.5
Granath, F.6
Rane, A.7
-
29
-
-
0028852095
-
Carcinoma of the prostate - State at initial presentation
-
Srinivas V, Mehta H, Amin A, Choudary R, Gadgil N, Ravishanker D, Phadke AG. Carcinoma of the prostate - state at initial presentation. Int Urol Nephrol. 1995;27:419-422.
-
(1995)
Int Urol Nephrol
, vol.27
, pp. 419-422
-
-
Srinivas, V.1
Mehta, H.2
Amin, A.3
Choudary, R.4
Gadgil, N.5
Ravishanker, D.6
Phadke, A.G.7
-
30
-
-
0036869078
-
CAG repeat expansion in the androgen receptor gene is not associated with male infertility in Indian populations
-
Thangaraj K, Joshi MB, Reddy AG, Gupta NJ, Chakravarty B, Singh L. CAG repeat expansion in the androgen receptor gene is not associated with male infertility in Indian populations. J Androl. 2002;23:815-818. (Pubitemid 36300971)
-
(2002)
Journal of Andrology
, vol.23
, Issue.6
, pp. 815-818
-
-
Thangaraj, K.1
Joshi, M.B.2
Reddy, A.G.3
Gupta, N.J.4
Chakravarty, B.5
Singh, L.6
-
31
-
-
0037458112
-
Genetic affinities of the Andaman Islanders, a vanishing human population
-
DOI 10.1016/S0960-9822(02)01336-2, PII S0960982202013362
-
Thangaraj K, Singh L, Reddy AG, Rao VR, Sehgal SC, Underhill PA, Pierson M, Frame IG, Hagelberg E. Genetic affinities of the Andaman Islanders, a vanishing human population. Curr Biol. 2003;13:86-93. (Pubitemid 36154335)
-
(2003)
Current Biology
, vol.13
, Issue.2
, pp. 86-93
-
-
Thangaraj, K.1
Singh, L.2
Reddy, A.G.3
Rao, V.R.4
Sehgal, S.C.5
Underhill, P.A.6
Pierson, M.7
Frame, I.G.8
Hagelberg, E.9
-
32
-
-
0027234897
-
Tissue distribution and ontogeny of steroid 5-reductase isozyme expression
-
Thigpen AE, Silver RI, Guileyardo JM, Casey ML, McConnell JD, Russell DW. Tissue distribution and ontogeny of steroid 5-reductase isozyme expression. J Clin Invest. 1993;92:903-910.
-
(1993)
J Clin Invest
, vol.92
, pp. 903-910
-
-
Thigpen, A.E.1
Silver, R.I.2
Guileyardo, J.M.3
Casey, M.L.4
McConnell, J.D.5
Russell, D.W.6
-
33
-
-
0025806437
-
Androgen receptors in endocrine-therapy-resistant human prostate cancer
-
van der Kwast TH, Schalken J, Ruizeveld de Winter JA, van Vroonhoven CC, Mulder E, Boersma W, Trapman J. Androgen receptors in endocrine-therapy- resistant human prostate cancer. Int J Cancer. 1991;48:189-193.
-
(1991)
Int J Cancer
, vol.48
, pp. 189-193
-
-
Van Der Kwast, T.H.1
Schalken, J.2
Ruizeveld De Winter, J.A.3
Van Vroonhoven, C.C.4
Mulder, E.5
Boersma, W.6
Trapman, J.7
-
35
-
-
0028846963
-
Serum androgens and sex-hormone binding globulins in relation to lifestyle factors in older African-American, white, and Asian men in the United States and Canada
-
Wu AH, Whittemore AS, Kolonel LN, John EM, Gallagher RP, West DW, Hankin J, The CZ, Dreon DM, Paffenbarger RS Jr. Serum androgens and sex-hormone binding globulins in relation to lifestyle factors in older African-American, white, and Asian men in the United States and Canada. Cancer Epidemiol Biomark Prev. 1995;4:735-741.
-
(1995)
Cancer Epidemiol Biomark Prev
, vol.4
, pp. 735-741
-
-
Wu, A.H.1
Whittemore, A.S.2
Kolonel, L.N.3
John, E.M.4
Gallagher, R.P.5
West, D.W.6
Hankin, J.7
The, C.Z.8
Dreon, D.M.9
Paffenbarger Jr., R.S.10
-
36
-
-
0035371666
-
Impact of genetic polymorphisms of 17-hydroxylase cytochrome P-450 (CYP17) and steroid 5alpha-reductase type II (SRD5A2) genes on prostate-cancer risk among the Japanese population
-
DOI 10.1002/1097-0215(20010601)92:5<683::AID-IJC1255>3.0.CO;2-4
-
Yamada Y, Watanabe M, Murata M, Yamanaka M, Kubota Y, Ito H, Katoh T, Kawamura J, Yatani R, Shiraishi T. Impact of genetic polymorphisms of 17-hydroxylase cytochrome P-450 (CYP17) and steroid 5α-reductase type II (SRD5A2) genes on prostate cancer risk among the Japanese population. Int J Cancer. 2001;92:683-686. (Pubitemid 32385710)
-
(2001)
International Journal of Cancer
, vol.92
, Issue.5
, pp. 683-686
-
-
Yamada, Y.1
Watanabe, M.2
Murata, M.3
Yamanaka, M.4
Kubota, Y.5
Ito, H.6
Katoh, T.7
Kawamura, J.8
Yatani, R.9
Shiraishi, T.10
-
38
-
-
0028900073
-
The nonamer UUAUUUAUU is the key AU-rich sequence motif that mediates mRNA degradation
-
Zubiaga AM, Belasco JG, Greenberg ME. The nonamer UUAUUUAUU is the key AU-rich sequence motif that mediates mRNA degradation. Mol Cell Biol. 1995;15:2219-2230.
-
(1995)
Mol Cell Biol
, vol.15
, pp. 2219-2230
-
-
Zubiaga, A.M.1
Belasco, J.G.2
Greenberg, M.E.3
|